Bristol-Myers Squibb (BMS) is suing AstraZeneca Pharmaceuticals, alleging that the Anglo-Swedish drugmaker’ Imfinzi to treat lung and bladder cancer infringes several...
French API specialist Seqens is investing what it says is a multi-million-dollar sum in its US research and development laboratory at Devens, Massachusetts. The company...
Gearing up for a potential proxy fight at its Mar. 25 annual meeting, Huntsman has written to its shareholders urging them to vote for the company’s nominated directors...
Azelis has bought Whitfield Chemical, the owner of WhitChem, a UK distributor focused on the coatings, adhesives, sealants and elastomers (CASE) and rubber and plastic...
Dutch storage operator Stolthaven Terminals has signed a Memorandum of Understanding with the Pecém Industrial and Port Complex, a joint venture between the Ceará State...
Pfizer and BioNTech have submitted an application to the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of an additional booster dose of...
Indian engineering and construction company Nuberg EPC has been awarded a contract by Fertilisers and Chemicals Travancore (FACT) to build a brownfield NPK/diammonium...
Shipping giant A.P. Moller-Maersk has entered into strategic partnerships with six companies with the aim of sourcing at least 730,000 t/y of green methanol by the end of...
Viatris, the new US pharma created in the 2020 merger of Mylan and Pfizer’s Upjohn off-patent franchise, is selling its biosimilars portfolio to Biocon Biologics for up...
Johnson Matthey has entered into a Memorandum of Understanding (MoU) with 8 Rivers Capital to commercialize the latter’s clean hydrogen process, known as 8RH2. The...
